Winston Medical Supply Co., Ltd. (6817.TWO)
TWD 91.2
(0.0%)
TWD 91.2
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 215.44 Million | 124.88 Million | 146.45 Million | 111.74 Million | 49.75 Million |
| Net Income | 198.81 Million | 141.39 Million | 116.58 Million | 85.75 Million | -9.35 Million |
| Depreciation & Amortization | 27.97 Million | 36.29 Million | 36.12 Million | 36.18 Million | 35.88 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 148 Thousand |
| Change in working capital | 25.19 Million | -33.14 Million | -7.39 Million | -9.57 Million | 7.52 Million |
| Other non-cash items | -483 Thousand | 661 Thousand | 1.67 Million | 3.03 Million | 15.56 Million |
| Investing Cash Flow | -19.88 Million | -8.62 Million | -6.1 Million | 544 Thousand | -1.11 Million |
| Investments in PPE | -20.04 Million | -6.55 Million | -5.13 Million | -3.19 Million | -6.46 Million |
| Acquisitions | - | - | - | - | 6.85 Million |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 160 Thousand | -2.07 Million | -963 Thousand | 2.85 Million | 5.35 Million |
| Financing Cash Flow | -99.09 Million | -76.39 Million | -123.89 Million | -87.47 Million | -33.37 Million |
| Debt repayment | -4.7 Million | -4.7 Million | -74.31 Million | -102.69 Million | -33.37 Million |
| Dividends payments | -92.08 Million | -73.66 Million | -55.25 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 5 Million | 13.34 Million | - |
| Other Financing Activities | -2.3 Million | 3.31 Million | 1.92 Million | 2.92 Million | - |
| Accounts receivables | 2.67 Million | 7.45 Million | -12.76 Million | -17.24 Million | -8.04 Million |
| Accounts payables | 8.02 Million | - | - | - | - |
| Inventory | -19.3 Million | 10.24 Million | 1.38 Million | -1.67 Million | -4.19 Million |
| Other working capital | 34.05 Million | -57.47 Million | 6.49 Million | -11.83 Million | 19.76 Million |
| Cash at beginning of period | 202.67 Million | 162.8 Million | 146.34 Million | 121.53 Million | 106.25 Million |
| Cash at end of period | 299.13 Million | 202.67 Million | 162.8 Million | 146.34 Million | 121.53 Million |
| Capital Expenditure | -20.04 Million | -6.55 Million | -5.13 Million | -3.19 Million | -6.46 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 96.46 Million | 39.86 Million | 16.45 Million | 24.81 Million | 15.27 Million |
| Free Cash Flow | 195.4 Million | 118.33 Million | 141.31 Million | 108.54 Million | 43.29 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 31.92 Million | 31.92 Million | 42.98 Million | 198.81 Million | 42.98 Million | 36.39 Million |
| Depreciation & Amortization | 7.28 Million | 7.28 Million | 7.1 Million | 27.97 Million | 7.1 Million | 6.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 941 Thousand | 941 Thousand | 13.63 Million | 25.19 Million | 13.63 Million | -4.92 Million |
| Other non-cash items | -5.19 Million | -5.19 Million | -3.99 Million | -483 Thousand | -3.99 Million | 9.89 Million |
| Investing Cash Flow | -4.85 Million | -4.85 Million | -8.09 Million | -19.88 Million | -8.09 Million | -1.84 Million |
| Investments in PPE | -4.58 Million | -4.58 Million | -7.47 Million | -20.04 Million | -7.47 Million | -2.04 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -275.5 Thousand | -275.5 Thousand | -621.5 Thousand | 160 Thousand | -621.5 Thousand | 198.5 Thousand |
| Financing Cash Flow | -1.96 Million | -1.96 Million | -77.99 Million | -99.09 Million | -77.99 Million | 28.45 Million |
| Debt repayment | -5.18 Million | - | - | -4.7 Million | - | - |
| Dividends payments | - | - | -46.04 Million | -92.08 Million | -46.04 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.96 Million | -1.96 Million | -31.95 Million | - | -31.95 Million | 28.45 Million |
| Accounts receivables | 2.28 Million | 2.28 Million | -2.51 Million | 2.67 Million | -2.51 Million | 3.85 Million |
| Accounts payables | -3.92 Million | - | - | - | - | - |
| Inventory | -4.79 Million | -4.79 Million | -4.12 Million | -19.3 Million | -4.12 Million | -5.52 Million |
| Other working capital | 3.45 Million | 3.45 Million | 20.27 Million | 34.05 Million | 20.27 Million | -3.24 Million |
| Cash at beginning of period | 299.13 Million | - | - | 202.67 Million | - | - |
| Cash at end of period | 28.13 Million | 28.13 Million | -26.35 Million | 299.13 Million | -26.35 Million | 74.58 Million |
| Capital Expenditure | -4.58 Million | -4.58 Million | -7.47 Million | -20.04 Million | -7.47 Million | -2.04 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -271 Million | 28.13 Million | -26.35 Million | 96.46 Million | -26.35 Million | 74.58 Million |
| Free Cash Flow | 30.37 Million | 30.37 Million | 52.26 Million | 195.4 Million | 52.26 Million | 45.94 Million |
7361
5162
0F2S
HYSG
ARCT
IOFNF